Skip to content
★ Sign in to follow
JH

Jane H. Hollingsworth

Board Director
Director
CervoMed Inc.Nupathe Inc.
Total declarations
17
Companies
2
▲ Purchases (2 ops.)
€53k
▼ Sales (0 ops.)
—

Latest filing published 06 Sept 2023 for CervoMed Inc..

Filing timeline

BuySale
Jane H. Hollingsworth

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 17 May 2021 · 2002 days ago · €17k
    -80.2%
    Entry US$56.25 · Close at T+365 US$11.16

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Jane H. Hollingsworth: trading record in brief

Jane H. Hollingsworth, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in CervoMed Inc. and Nupathe Inc. Between 11 August 2010 and 31 August 2023, the trades on record add up to 17 filings.

Purchases make up the whole of the open-market record (2 purchases, €53k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 option exercises.

On 6 September 2023 came the latest disclosure, a transaction in CervoMed Inc. The clock since the last published purchase (17 May 2021) now reads 2,002 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Jane H. Hollingsworth

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations